Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis

Gut

Volumn 64, Issue 7, 2015, Pages 1082-1094

  Wu, Shaoping ^a   Zhang, Yong Guo ^a   Lu, Rong ^a   Xia, Yinglin ^b   Zhou, David ^c   Petrof, Elaine O ^d   Claud, Erika C ^e   Chen, Di ^a   Chang, Eugene B ^e   Carmeliet, Geert ^f   Sun, Jun ^a  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d GI Diseases Research Unit   (Canada)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DEXTRAN SULFATE; LYSOZYME; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATG16L1 GENE; AUTOPHAGY; BACTEROIDES; COLITIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM; INTESTINE FLORA; MOUSE; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPRECIPITATION; INBRED MOUSE STRAIN; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOPHAGY; COLITIS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINAL MUCOSA; MICE, INBRED STRAINS; MICE, KNOCKOUT; MIDDLE AGED; PANETH CELLS; RECEPTORS, CALCITRIOL;

EID: 84935020276     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307436     Document Type: Article

References (108)

1. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci 2009; 1173:384-90.
2. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4:404-12.
3. Grau MV, Baron JA, Sandler R.S., et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003; 95:1765-71.
4. Gocek E, Studzinski GP. Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 2009; 46:190-209.
5. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3:1535-41.
6. Cannell JJ, Hollis BW, Zasloff M, et al. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008; 9:107-18.
7. Campbell FC, Xu H, El-Tanani M, et al. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol 2009; 79:1-9.
8. Abreu MT, Kantorovich V, Vasiliauskas E.A., et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density. Gut 2004; 53:1129-36.
9. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:308-15.
10. Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002; 76:1077-81.
11. Haussler MR, Whitfield GK, Haussler C.A., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13:325-49.
12. Demay MB. Mechanism of vitamin D receptor action. Ann N Y Acad Sci 2006; 1068:204-13.
13. Tsoukas CD, Provvedini DM, Manolagas SC. 1, 25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224:1438-40.
14. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
15. Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59:881-6.
16. Yu S, Bruce D, Froicu M., et al. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci U S A 2008; 105:20834-9.
17. Stio M, Martinesi M, Bruni S., et al. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. Int Immunopharmacol 2006; 6:1083-92.
18. Dresner-Pollak R, Ackerman Z, Eliakim R., et al. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004; 8:417-20.
19. Simmons JD, Mullighan C, Welsh K.I., et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47:211-14.
20. Ananthakrishnan AN, Khalili H, Higuchi L.M., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142:482-9.
21. Hughes DJ, McManus R, Neary P., et al. Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case-control study. Eur J Gastroenterol Hepatol 2011; 23:807-12.
22. Eloranta JJ, Wenger C, Mwinyi J., et al. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics 2011; 21:559-64.
23. Wada K, Tanaka H, Maeda K., et al. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep 2009; 22:1021-5.
24. Froicu M, Zhu Y, Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006; 117:310-18.
25. Wu S, Xia Y, Liu X., et al. Vitamin D receptor deletion leads to reduced level of IkappaBalpha protein through protein translation, protein-protein interaction, and post-translational modification. Int J Biochem Cell Biol 2010; 42:329-36.
26. Liu W, Chen Y, Golan M.A., et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 2013; 123:3983-96.
27. Kato S. The function of vitamin D receptor in vitamin D action. J Biochem 2000; 127:717-22.
28. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 2005; 19:1067-77.
29. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-12.
30. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 2009; 494:166-77.
31. Bouillon R, Carmeliet G, Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29:726-76.
32. Carlberg C, Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res 2009; 29:3485-93.
33. Protiva P, Cross HS, Hopkins M.E., et al. Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila Pa) 2009; 2:43-51.
34. Murillo G, Mehta RG. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5. J Steroid Biochem Mol Biol 2005; 97:129-36.
35. Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 2009; 28:3892-902.
36. Fichera A, Little N, Dougherty U., et al. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 2007; 142:239-45.
37. Nagpal S, Lu J, Boehm MF. Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem 2001; 8:1661-79.
38. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, et al. Genetic signatures of differentiation induced by 1alpha, 25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 2003; 63:7799-806.
39. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010; 138:2029-43. e10.
40. Trowbridge R, Mittal SK, Agrawal DK. Vitamin d and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomarkers Prev 2013; 22:1007-14.
41. Liu PT, Stenger S, Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
42. Koslowski MJ, Beisner J, Stange E.F., et al. Innate antimicrobial host defense in small intestinal Crohn's disease. Int J Med Microbiol 2009; 300:34-40.
43. Wehkamp J, Wang G, Kubler I., et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179:3109-18.
44. Menard S, Forster V, Lotz M., et al. Developmental switch of intestinal antimicrobial peptide expression. J Exp Med 2008; 205:183-93.
45. Lau KS, Cortez-Retamozo V, Philips S.R., et al. Multi-scale in vivo systems analysis reveals the influence of immune cells on TNF-alpha-induced apoptosis in the intestinal epithelium. PLoS Biol 2012; 10:e1001393.
46. Takahashi N, Vanlaere I, de Rycke R, et al. IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 2008; 205:1755-61.
47. Adolph TE, Tomczak MF, Niederreiter L, et al. Paneth cells as a site of origin for intestinal inflammation. Nature 2013; 503:272-6.
48. Vaishnava S, Behrendt CL, Ismail A.S., et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 2008; 105:20858-63.
49. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469:323-35.
50. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21.
51. Barrett JC, Hansoul S, Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40:955-62.
52. Cadwell K. Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1. Gastroenterology 2010; 139:1448-50.
53. Hampe J, Franke A, Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39:207-11.
54. Deretic V, Master S, Singh S. Autophagy gives a nod and a wink to the inflammasome and Paneth cells in Crohn's disease. Dev Cell 2008; 15:641-2.
55. Thachil E, Hugot JP, Arbeille B, et al. Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn's disease. Gastroenterology 2012; 142:1097-9. e4.
56. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007; 27:549-59.
57. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11:55-62.
58. Saitoh T, Fujita N, Jang M.H., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264-8.
59. Cadwell K, Liu JY, Brown S.L., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456:259-63.
60. Verway M, Behr MA, White JH. Vitamin D, NOD2, autophagy and Crohn's disease. Expert Rev Clin Immunol 2010; 6:505-8.
61. Yuk JM, Shin DM, Lee H.M., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6:231-43.
62. Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 2012; 8:e1002689.
63. Sun J, Kong J, Duan Y., et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291:E315-22.
64. Sun J, Mustafi R, Cerda S., et al. Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells. J Steroid Biochem Mol Biol 2008; 111:37-40.
65. Wu S, Liao AP, Xia Y, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 2010; 177:686-97.
66. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 2011; 11:325-35.
67. Van Cromphaut SJ, Dewerchin M, Hoenderop J.G., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A 2001; 98:13324-9.
68. Hamamoto N, Maemura K, Hirata I., et al. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clin Exp Immunol 1999; 117:462-8.
69. Couturier-Maillard A, Secher T, Rehman A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013; 123:700-11.
70. Sellon RK, Tonkonogy S, Schultz M., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66:5224-31.
71. Lu R, Wu S, Liu X., et al. Chronic effects of a Salmonella type III secretion effector protein AvrA in vivo. PLoS One 2010; 5:e10505.
72. Franks AH, Harmsen HJ, Raangs G.C., et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64:3336-45.
73. Kochl R, Hu XW, Chan E.Y., et al. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 2006; 7:129-45.
74. Stamatiou R, Paraskeva E, Boukas K., et al. Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells. Eur Respir J 2009; 34:721-30.
75. Lagishetty V, Misharin AV, Liu N.Q., et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010; 151:2423-32.
76. Xu Z, Shen F, Li X., et al. Molecular and microscopic analysis of bacteria and viruses in exhaled breath collected using a simple impaction and condensing method. PLoS One 2012; 7:e41137.
77. Fan Y, Dickman KG, Zong WX. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem 2010; 285:7324-33.
78. Wang Y, Hoenig JD, Malin K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009; 3:944-54.
79. Devkota S, Wang Y, Musch M.W., et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487:104-8.
80. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71:8228-35.
81. Masuyama R, Stockmans I, Torrekens S., et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006; 116:3150-9.
82. Bloom SM, Bijanki VN, Nava G.M., et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011; 9:390-403.
83. Prindiville TP, Sheikh RA, Cohen S.H., et al. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 2000; 6:171-4.
84. Basset C, Holton J, Bazeos A., et al. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci 2004; 49:1425-32.
85. Rabizadeh S, Rhee KJ, Wu S, et al. Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 2007; 13:1475-83.
86. Kong J, Zhang Z, Musch M.W., et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294:G208-16.
87. Kabi A, Nickerson KP, Homer C.R., et al. Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis 2012; 18:782-92.
88. Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137:1001-4.
89. Komatsu M, Waguri S, Koike M., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007; 131:1149-63.
90. Zhang XQ, Dunner K Jr., Benedict WF. Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced. Cancer Gene Ther 2010; 17:579-84.
91. Li XY, Boudjelal M, Xiao J.H., et al. 1, 25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol 1999; 13:1686-94.
92. Herfarth HH, Mohanty SP, Rath H.C., et al. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996; 39:836-45.
93. Machiels K, Joossens M, Sabino J., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63:1275-83.
94. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39:125-36.
95. Lu R, Wu S, Xia Y., et al. The vitamin D receptor, inflammatory bowel diseases, and colon cancer. Curr Colorectal Cancer Rep 2012; 8:57-65.
96. Parkes M. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis. Dig Dis 2012; 30:330-3.
97. Randall-Demllo S, Chieppa M, Eri R. Intestinal epithelium and autophagy: partners in Gut homeostasis. Front Immunol 2013; 4:301.
98. Hwang S, Maloney NS, Bruinsma M.W., et al. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 2012; 11:397-409.
99. Phan TG, Green JA, Gray E.E., et al. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol 2009; 10:786-93.
100. Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol 2009; 10:461-70.
101. Wang D, Peregrina K, Dhima E., et al. Paneth cell marker expression in intestinal villi and colon crypts characterizes dietary induced risk for mouse sporadic intestinal cancer. Proc Natl Acad Sci USA 2011; 108:10272-7.
102. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011; 9:356-68.
103. Ouellette AJ. Paneth cell alpha-defensins in enteric innate immunity. Cell Mol Life Sci 2011; 68:2215-29.
104. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008; 134:743-56.
105. Salzman NH, Hung K, Haribhai D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-83.
106. Schauber J, Svanholm C, Termen S., et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003; 52:735-41.
107. Segaert S. Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology? J Invest Dermatol 2008; 128:773-5.
108. Zeeuwen PL, Kleerebezem M, Timmerman H.M., et al. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol 2013; 13:514-20.